Skip to search formSkip to main contentSkip to account menu

MYDRIATICS AND CYCLOPLEGICS

Known as: mydriatic/cycloplegic 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (2)

CycloplegicsMydriatics

Broader (1)

OPHTHALMIC AGENTS

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Estimating cycloplegic retinoscopy by school bus accommodation-relaxing skiascopy (SBA-RS)
2015
2015
Frequency of refractive errors and binocular vision anomalies in children with learning disability
Summary Purpose To determine the frequency of refractive errors and binocular vision anomalies in children with learning… 
2013
2013
How to Medically Manage a Case of Equine Eosinophilic Keratoconjunctivitis
Equine eosinophilic keratitis or keratoconjunctivitis (EK) is an inflammatory disease of the conjunctiva and cornea. This disease… 
2013
2013
Tratamento medicamentoso de ulceração corneana e abscesso estromal em equinos
Background: The equine eyelids and cilia protect the eye and promote normal ocular physiological function. Disorders in these… 
2011
2011
L’uso dei farmaci oftalmologici nella popolazione pediatrica in italia
Summary Aim - A study was planned to analyse the availability and the licensing status of ocular drugs marketed in Italy and… 
2005
2005
Patterns of spectacle use in young Australian school children: findings from a population-based study.
Review
2005
Review
2005
Contemporary issues in amblyopia treatment.
Review
1990
Review
1990
The Canadian Optometry Survey: report on the utilization of diagnostic pharmaceutical agents by Canadian optometrists.
This study represents the first national survey of optometrists in Canada. A mailed questionnaire was designed and implemented in… 
1982
1982
Memo on medications: atropine sulfate and homatropine hydrobromide: common mydriatic/cycloplegic agents.
1982
1982
Memo on medications: atropine sulfate and homatropine hydrobromide: common mydriatic/cycloplegic agents.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)